KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to $258.2 million.

  • Fulgent Genetics' Short-term Investments rose 6652.71% to $258.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $258.2 million, marking a year-over-year increase of 6652.71%. This contributed to the annual value of $203.0 million for FY2024, which is 3787.15% down from last year.
  • Per Fulgent Genetics' latest filing, its Short-term Investments stood at $258.2 million for Q3 2025, which was up 6652.71% from $205.0 million recorded in Q2 2025.
  • Over the past 5 years, Fulgent Genetics' Short-term Investments peaked at $446.7 million during Q4 2022, and registered a low of $155.0 million during Q3 2024.
  • Over the past 5 years, Fulgent Genetics' median Short-term Investments value was $258.3 million (recorded in 2021), while the average stood at $297.9 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first skyrocketed by 142902.32% in 2021, then tumbled by 5959.96% in 2024.
  • Fulgent Genetics' Short-term Investments (Quarter) stood at $285.6 million in 2021, then soared by 56.41% to $446.7 million in 2022, then dropped by 26.87% to $326.7 million in 2023, then plummeted by 37.87% to $203.0 million in 2024, then rose by 27.2% to $258.2 million in 2025.
  • Its Short-term Investments was $258.2 million in Q3 2025, compared to $205.0 million in Q2 2025 and $253.0 million in Q1 2025.